Effect of lactulose and fiber-rich diets on bile in relation to gallstone disease: An update

Scandinavian Journal of Gastroenterology, Supplement

Volumn 32, Issue 222, 1997, Pages 68-71

  Vanberge Henegouwen, G P ^a   Portincasa, P ^b   Van Erpecum, K J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

bile acid metabolism; biliary cholesterol saturation; cholesterol gallstones; deoxycholate; fiber rich diets; lactulose

Indexed keywords

CHOLESTEROL; DEOXYCHOLIC ACID; LACTULOSE; GASTROINTESTINAL AGENT;

BILE ACID METABOLISM; DIETARY FIBER; GALLSTONE; GASTROINTESTINAL TRANSIT; HUMAN; PRIORITY JOURNAL; REVIEW; BILE; CHEMISTRY; CHOLELITHIASIS; DRUG EFFECT; METABOLISM;

BILE; CHOLELITHIASIS; CHOLESTEROL; DEOXYCHOLIC ACID; DIETARY FIBER; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRANSIT; HUMANS; LACTULOSE;

EID: 0030627612     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Portincasa P, Stolk MFJ, Van Erpecum KJ, Palasciano G, VanBerge-Henegouwen OP. Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect. Scand J Gastroenterol 1995;30 Suppl 212:63-78.
2. Van Erpecum KJ, VanBerge-Henegouwen GP, Stoelwinder B, Schmidt YMG, Willekens FLH. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients. Hepatology 1990;11:1-6.
3. Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzella G, Festi D, et al. Gallstone recurrence after successful oral bile acid treatment: a 12 year follow-up study and evaluation of long-term post-dissolution treatment. Gastroenterology 1989;97:726-31.
4. Groen AK, Noordam C, Drapers JAG, Egbers P, Jansen PLM, Tytgat GNJ. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile of patients with solitary or multiple cholesterol gallstones. Hepatology 1990;11:525-33.
5. Portincasa P, Van Erpecum KJ, Van de Meeberg P, Dullinga-Thie GM, De Bruin TWA, VanBerge-Henegouwen GP. Apolipoprotein E genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extra-corporeal shock-wave lithotripsy. Hepatology 1996;24:580-7.
6. Marcus SN, Heaton KW. Deoxycholic acid and the pathogenesis of gallstones. Gut 1988;29:522-33.
7. Marcus SN, Heaton KW. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile - three interrelated factors. Gut 1986;27:550-8.
8. Heaton KW, Emmett PM, Symes CL, Braddon FEM. An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet 1993;341:8-10.
9. Shoda J, He B-F, Tanaka N, Matsuzaki Osuga T, Yamamori S, Miyazaki H, Sjovall J. Increase of deoxycholate in super-saturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology 1995;21:1291-302.
10. Hussani SH, Murphy GM, Kennedy C, Besser GM, Wass JAH, Dowling RH. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology 1994;107:1503-13.
11. Berr F, Pratschke E, Fischer S, Paumgartner G. Disorders of bile acid metabolism in cholesterol gallstone disease. J Clin Invest 1992;90:859-68.
12. Vlahcevic ZR, Bell Jr CC, Buhac I, Farrar JT, Swell L. Diminished bile acid pool size in patients with gallstones. Gastroenterology 1970;59:165-73.
13. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59:828-40.
14. Nilsell KB, Angelin B, Leijd B, Einarsson K. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Gastroenterology 1985;89:287-93.
15. Carulli N, Loria P, Bertolotti C, Ponz de Leon M, Menozzi D, Medici G, Piccagli I. Effects of acute changes in bile acid pool composition on biliary lipid secretion. J Clin Invest 1985;74: 616-24.
16. Xu Q-W, Shaffer EA. Octreotide inhibits biliary lipid secretion and GB motility: relation to cholesterol gallstone formation. Gastroenterology 1995;108:A442.
17. Xu Q-W, Scott RB, Tan DTM, Shaffer EA. Slow intestinal transit: an added motility disorder in cholesterol gallstone formation. Gastroenterology 1995;108:A442.
18. Xu Q-W, Scott RB, Tan DTM, Shaffer EA. Erythromycin as a prokinetic agent in an animal model of cholesterol gallstone disease. Gastroenterology 1995;108:A441.
19. Attili AF, Carulli M, Roda E, Barbara L, Capocaccia L, Menotti A, the M.I.C.O.L. group. Epidemiology of gallstone disease in Italy: prevalence data of the multicenter Italian Study on cholelithiasis (M.I.C.O.L.). Am J Epidemiol 1995;141:158-65.
20. Van der Werf SDJ, Huybregts AWM, Lamers HLM, VanBerge-Henegouwen GP. Age-dependent differences in human bile acid metabolism and 7α-dehydroxylation. Eur J Clin Invest 1981;11: 425-31.
21. Einarsson K, Milsell K, Björkhem I. Increased oxidoreduction of deoxycholic acid in cholecystectomised patients. Gut 1989;30: 1275-8.